As TAVR continues to gain popularity, researchers remain focused on discovering new ways to predict short- and long-term outcomes. One recent study, for example, explored the potential of AI-enabled imaging assessments. Another analysis focused on the CALLY index.
The 4D system harnesses X-ray diffraction to measure molecular-level signatures of disease; these tissue “fingerprints” could help providers diagnose breast cancer in its earliest stages.
Federal authorities said the shift to regional “Strike Force” models has proven successful, with 6,200 defendants prosecuted nationwide. The DOJ said this latest unit will take a special interest in Northern California.
WakeMed, a three-hospital system in the North Carolina capital region of Raleigh, would become part of Advocate Health, Atrium’s parent company, if the deal goes through. Advocate is one of the largest not-for-profit health systems in the U.S.
The New Jersey-based drug developer joins AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer in offering products directly to patients at a discounted rate. Johnson & Johnson is currently listing four medications on the platform.
Frustratingly to hospital leadership, the upward trajectory in attacks and harms is happening despite healthcare’s striving—and spending—to be more proactive with defensive measures.
Corresponding with the change, the Chicago-based imaging manufacturer is combing two of its radiology-related business lines into a new segment worth $14.6 billion.
Funding will help the New York-based company expand into additional clinical indications and capabilities while also supporting further development of Aidoc’s CARE Foundation Model.
Certain corners of the healthcare AI industry continue hyping the notion that their technology will render physicians unneeded. Young people, including potential medical students, might believe the claim. Here’s help.
Check Point Research revealed in a new report that VECT 2.0—advertised as a powerful, secure ransomware service—contains a fatal coding error that wipes victims’ data instead of encrypting it.
As TAVR continues to gain popularity, researchers remain focused on discovering new ways to predict short- and long-term outcomes. One recent study, for example, explored the potential of AI-enabled imaging assessments. Another analysis focused on the CALLY index.
The 4D system harnesses X-ray diffraction to measure molecular-level signatures of disease; these tissue “fingerprints” could help providers diagnose breast cancer in its earliest stages.
